Safety and preliminary efficacy of allogeneic umbilical cord-derived mesenchymal stem cells administered via the hepatic artery in patients with liver cirrhosis: A phase I open-label trial. - Nguyen LT; Nguyen HP; Bui HT; Nguyen QT; Nguyen PV; Ha HTT (Cell transplantation, 2026)